64 results matched the archive and page content.
Point-of-care diagnostics are transforming rural healthcare by enabling rapid testing and informed decision-making in resource-limited settings, but deployment requires careful planning.
Companion diagnostics evidence matters when the test result changes a defined treatment decision for the population being served.
Point-of-care diagnostics create value when a reliable result reaches the person who must act on it.
Antimicrobial stewardship becomes operational when prescribing decisions, diagnostic evidence, resistance patterns, and feedback return to the clinical team.
AI in healthcare is easier to assess when a claim is tied to a workflow, a user, a failure mode, and a measured outcome rather than a category label. Start with the decision, not the model An AI tool matters because it c
Universal health coverage analysis is incomplete unless service access and the risk of financial hardship are read together.
Access to medicines, diagnostics, and devices depends on quality assurance, regulation, financing, and the purchasing route, not only on product supply.
Public buyers protect value when quality assurance, regulatory evidence, procurement decisions, and post-market action are joined before purchase.
Digital pathology and precision diagnostics claims are easier to assess when a result is tied to a validated specimen population, a comparator, and a workflow change.
Diagnostics analysis should follow the result from sample collection through interpretation, treatment, referral, and patient understanding.
AMR coverage is stronger when it follows the chain from detection and prescribing to infection prevention, supply, and stewardship.
Explore the global market for healthcare data annotation tools, essential for improving AI diagnostics and patient care accuracy.